SA Asks: Which biotechs could be acquired by year's end?
Source: SeekingAlpha
2025-09-13 16:18:46 ET
More on Eli Lilly, Novo Nordisk, etc.
- The GLP-1 Oral Frontier: Novo Nordisk And Eli Lilly's 100-Year Duel Enters Its Next Chapter
- Novo Nordisk: GLP-1's Concerns Are Overblown
- Novo Nordisk: Restructuring And Reduced Guidance Set Up A Cleaner 2026
- Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports
- Trump is said to force Big Pharma to lower drug prices within weeks
Read the full article on Seeking Alpha
For further details see:
SA Asks: Which biotechs could be acquired by year's end?
Zealand Pharma A/S Ord
NASDAQ: ZLDPF
ZLDPF Trading
0.29% G/L:
$41 Last:
773 Volume:
$41.465 Open:
ZLDPF Latest News
March 09, 2026 12:01:00 pm
Zealand Pharma to participate in upcoming investor conferences in March 2026
ZLDPF Stock Data
$4,529,461,750
63,016,002
N/A
117
N/A
Biotechnology & Life Sciences
Healthcare
DK
Soborg
